|
New York, NY, November 18, 2009-CFFO-NEWS reports that negative Cash Flow from Operations (CFFO) for GTC Biotherapeutics, Inc. (NASDAQ:GTCB) for its quarter ended September 30, 2009 was $(9,982,000), ... read full story |
|
| Website Address: |
www.gtc-bio.com |
| Industry: |
Biomaterial & Tissue Engineering
|
|